Astellas Chairman and Daiichi Sankyo President Elected New Presidents Of FPMA And JPMA
This article was originally published in PharmAsia News
Executive Summary
Two pharmaceutical industry trade associations elected new president at elections held May 21. Federation of Pharmaceutical Manufacturers Association of Japan elected Astellas Chairman Toichi Takenaka as its new president, and Japan Pharmaceutical Manufacturers Association elected Daiichi Sankyo President Takeshi Shoda as its new president. Takenaka and Shoda played leading roles in M&A of Fujisawa and Yamanouchi to create Astellas, and Sankyo with Daiichi. Attention will be focused on how they tackle a series of challenges facing the industry, such as drug pricing and global competition. (Click here for more - Japanese language)
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.